Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |